menu

Blizard Institute

About menu

News

First evidence that soot from polluted air may be reaching placenta
16 September 2018

Evidence of tiny particles of carbon, typically created by burning fossil fuels, has been found in placentas for the first time, in early research involving a small number of people, presented today by researchers from Queen Mary University of London.

Study links widely-used drug azathioprine to skin cancers
10 September 2018

A drug used to treat inflammatory bowel disease and arthritis, and prevent organ rejection in transplant patients, has been identified as an important contributor to skin cancer development, in research by Queen Mary University of London, University of Dundee and the Wellcome Sanger Institute.

Queen Mary academic recognised for outstanding impact on students
30 August 2018

A leading higher education professional association, Advance HE, has awarded Dr Vicky Jolliffe from Queen Mary University of London a 2018 National Teaching Fellow award.

Stem cell transplants to be used in treating Crohn’s disease
6 August 2018

A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK.

Working towards a common goal of solving child malnutrition
2 August 2018

Ruairi Robertson is a Sir Henry Wellcome Postdoctoral Research Fellow based at the Blizard Institute, Queen Mary University of London. In the second part of his blog covering a recent trip to Zimbabwe, he reports from a symposium bringing together experts from all over the world and from different fields, who are hoping to find a solution to widespread child malnutrition.

Cannabinoid improves survival rates of mice with pancreatic cancer
31 July 2018

A new study led by Queen Mary University of London and Curtin University, Australia found that Cannabinoid improves survival rates of mice with pancreatic cancer.

Zimbabwe’s new era and hopes for treating child malnutrition
31 July 2018

Ruairi Robertson is a Sir Henry Wellcome Postdoctoral Research Fellow based at the Blizard Institute, Queen Mary University of London. In this two-part blog, he describes his recent trip to Zimbabwe where he and his team are carrying out research into severe acute malnutrition.

New study to examine the brain health of former footballers
18 July 2018

Former players will be recruited through the Professional Footballers’ Association for a study examining the link between heading the ball or concussions and long-term brain function.

Looking inside online health communities for people with chronic diseases: what holds them up?
12 July 2018

15 million adults in England have a long-term condition (LTC) and can access online peer support. Online health communities can influence health, use of healthcare resources, and improve illness self-management. The way people connect online and in particular how highly active users (called superusers) shape the online communities play a fundamental role in information diffusion, according a study published today in the journal JMIR.

Q&A: How a DNA repair gene can cause bone marrow failure
11 July 2018

Dr Hemanth Tummala and colleagues from the Blizard Institute had research published this week in the journal PNAS, which finds a new role for a gene in DNA repair.

Primarily funded by the Medical Research Council and Bloodwise charity, the researchers studied children with inherited bone marrow failure (IBMF) to find mutations that might be causing their disease.

In this Q&A, Dr Tummala explains the significance of the research and how it might lead to new treatments for cancer.

First clinical trial to recognise the needs of severely disabled MS patients
14 June 2018

A new clinical trial testing a disease-modifying drug for multiple sclerosis (MS) will be the first in the world to recognise the importance of wheelchair users retaining the use of their hands. 

The team from Queen Mary University of London, Barts Health NHS Trust and pharmaceutical company Roche, hope that the study will make lasting changes in a field that has previously only looked at a patient’s walking ability when assessing the potential of MS drugs.

Schools join research into the effect of air pollution on children’s health
13 June 2018

Over 3,000 primary school children in polluted areas of London and Luton will have their lung health monitored over a four-year period in a new international study led by Queen Mary University of London, launched today by the Mayor of London Sadiq Khan at Netley Primary School.

New lab technology could reveal treatments for muscle-wasting disease
6 June 2018

Researchers from Queen Mary University of London have developed new cell-based technologies which could improve understanding of the muscle-wasting disease Duchenne muscular dystrophy (DMD) and test potential drugs for the disease.

BRAIN Study progressing well
6 June 2018

  • Second round of participant recruitment due to start
  • Watch video here

School programme developed to empower young people to manage asthma better
4 June 2018

Researchers at Queen Mary University of London have developed a school programme to reduce high levels of poorly managed asthma in young people.

Fellows inaugurated at new Rutherford Academy of Population Genomics and Health Data Science
14 May 2018

Queen Mary University of London has appointed four research fellows to its new Rutherford Academy of Population Genomics and Health Data Science, funded by the Medical Research Council and UK Research and Investment’s Rutherford Fund.

New research funding brings new hope for Duchenne Muscular Dystrophy
9 May 2018

Barts Charity and Action Duchenne have combined forces to support research into new stem cell therapies for Duchenne Muscular Dystrophy. With a combined award of £276,000 (£250,000 from Barts Charity and £26,000 from Action Duchenne) they will be supporting the research of Dr Yung-Yao Lin, lecturer at the Barts and The London School of Medicine and Dentistry, Queen Mary University of London.

More than £50 million awarded to improve health and social care research
9 May 2018

Queen Mary University of London has received funding from the National Institute of Health Research (NIHR) to advise researchers on how to develop high quality research proposals.

Neuron Pod coming to Whitechapel
16 April 2018

Construction has started on Centre of the Cell’s new ‘Neuron Pod’ - a striking 10-metre high free-standing structure in the mews area of the Blizard Institute at Whitechapel.

Tuberculosis awareness animation launched for World TB Day
28 March 2018

A new health promotion tool has been launched to inform people about latent tuberculosis (TB) and engage migrant communities with local NHS testing and treatment.

One in ten stroke survivors need more help with taking medication
21 March 2018

Over a half of stroke patients require a degree of help with taking medicine and a sizeable minority say they do not receive as much assistance as they need, according a study by researchers at Queen Mary University of London and University of Cambridge.

Risk of maternal death doubled in pregnant women with anaemia
21 March 2018

Pregnant women with anaemia are twice as likely to die during or shortly after pregnancy compared to those without the condition, according to a major international study led by Queen Mary University of London of over 300,000 women across 29 countries.

Our curly hair was clue to hidden heart killer
19 March 2018

One woman tells CHRISTIE NORRIS how she finally discovered that she carries the deadly gene which has plagued her relatives for generations

Congratulations to Professor James Lindsey on his inaugural lecture
14 March 2018

The Blizard institute is very pleased to be able to celebrate the inaugural lecture of Professor James Lindsay which took place on Tuesday 13th March 2018 and addressed "Exploring the ‘ologies’ of Crohn’s disease: microbiology, immunology and stem-cell biology"

One in ten stroke survivors need more help with taking medication
12 March 2018

Over a half of stroke patients require a degree of help with taking medicine and a sizeable minority say they do not receive as much assistance as they need, according a study by researchers at Queen Mary University of London and University of Cambridge.

Health ministers and politicians visit brain tumour research labs
26 February 2018

UK health ministers shared the news of an upcoming funding boost to brain tumour research, during a visit to laboratories at Queen Mary University of London this week.

Long term health conditions drive A&E visits, not lack of GP services
16 January 2018

Rising accident and emergency attendance rates are driven by patients’ long term health conditions, and are not related to lack of GP provision, according to a study by Queen Mary University of London of more than 800,000 patients in east London.

Theatre project boosts peer support for young people with asthma
11 September 2017

An innovative theatre project and a game app have been presented by Queen Mary University of London (QMUL) researchers at the British Science Festival as new ways to help teenagers with asthma.

Professor Green launches 'Transform Trauma' fundraising appeal for QMUL research
26 July 2017

The rapper Professor Green is helping to raise funds for trauma research at Queen Mary University of London (QMUL) in a major appeal led by Barts Charity.

Moderate exercise and dieting reduces risk of caesarean section and diabetes in pregnancy
24 July 2017

Pregnant women who have a healthy diet and regular moderate exercise are less likely to have a caesarean section, gain excessive weight, or develop diabetes in pregnancy, according to a study led by Queen Mary University of London (QMUL) using data from over 12,000 women.

Sugar intake during pregnancy is associated with allergy and allergic asthma in children
6 July 2017

High maternal sugar intake during pregnancy may increase the risk of allergy and allergic asthma in the offspring, according to an early study led by Queen Mary University of London (QMUL) involving almost 9,000 mother-child pairs

Congratulations to Centre of the Cell on welcoming its 150,000th visitor in June 2017.
6 July 2017

The Blizard Institute’s science education centre, Centre of the Cell, reached a milestone of 150,000 participants in June 2017.

Congratulations to Professor Nick Croft on his inaugural lecture
30 June 2017

The Blizard institute is very pleased to be able to celebrate the inaugural lecture of Professor Nick Croft which took place on Wednesday 28 June and addressed ‘Children, Digestive Diseases and the Grand National’.

Congratulations to Professor Parveen -named in the Queen’s annual birthday honours
30 June 2017

Congratulations to Professor Parveen Kumar who was named in the Queen's annual Birthday Honours' list; been conferred the prestigious Dames Commander of the Order of the British Empire (DBE) for services to medicine and medical education.

The Everest Centre for Research into Paediatric Low Grade Brain Tumours
29 June 2017

Congratulations to Professor Denise Sheer who will be collaborating in a ground-breaking £5 million investment for research into Paediatric Low Grade Brain Tumours

Congratulations to Professor Tom Vulliamy on his inaugural lecture.
19 June 2017

The Blizard institute is very pleased to be able to celebrate the inaugural lecture of Professor Tom Vulliamy which took place on Friday the 15 June 2017. The lecture was title ‘Searching for genes – a long unwinding road’.

Previously unpublished trial data explain side effects of key MS drug
16 June 2017

Through a Freedom of Information request to the European Medicines Agency, researchers from Queen Mary University of London (QMUL) have gained access to data from drug trials, revealing new information about a key drug for multiple sclerosis (MS).

£1.5m awarded to apply preventive medicine to brain disorders
14 June 2017

Queen Mary University of London (QMUL) will establish a new Centre for Preventive Neurology, thanks to £1.5m of funding from Barts Charity.

Teenagers with asthma feel mocked for using their inhalers
14 June 2017

The research, published in BMJ Open, analysed posts written by teenagers and their parents from Asthma UK’s online forum between 2006 and 2016.  It found that the social stigma of asthma can play a role in teenagers choosing not to use their inhalers.

New research centre to improve health of women and unborn babies
13 June 2017

Queen Mary University of London (QMUL) has received £2m from Barts Charity to launch the Barts Research Centre for Women's Health, with the aim of tackling problems that affect mothers and their unborn and newborn children

Scans of brains and spinal cords reveal new insights into MS
12 May 2017

Some common assumptions about the nature of multiple sclerosis (MS) are being challenged in two new studies led by Queen Mary University of London (QMUL) that analyse the brains and spinal cords of patients.

£1.5m awarded to apply preventive medicine to brain disorders
2 May 2017

Queen Mary University of London (QMUL) will establish a new Centre for Preventive Neurology, thanks to £1.5m of funding from Barts Charity.

QMUL a partner in new world-leading health care improvement research institute
30 March 2017

The Health Foundation, an independent charity, has today announced funding in the region of £40 million over a period of 10 years for the University of Cambridge to establish and run a new improvement research institute, the first of its kind in Europe.

New tool predicts severe risks in mothers with pregnancy complications
30 March 2017

A new tool developed by researchers from Queen Mary University of London (QMUL) could save mothers’ and babies’ lives by predicting whether women with early onset pre-eclampsia are safe to prolong their pregnancy.

Toxic air warnings 'must include reminder for children to use inhalers'
30 March 2017

Londoners were warned of 'very high' pollution levels earlier this year AFP/Getty Images           

QMUL professor selected as NIHR senior investigator
30 March 2017

Congratulations to Professor Sandra Eldridge from the Centre for Primary Care and Public Health, who has been selected as a National Institute for Health Research (NIHR) senior investigator. Sandra’s success in this highly competitive process means that she will become a member of the NIHR College of around 200 senior investigators, charged with helping to shape and influence the future direction of health research and its benefits to the nation.

QMUL researchers among winners announced for £2m programme to commercialise life sciences discoveries
22 March 2017

Congratulations to Dr Rosalind Hannen and Professor Kenny Linton  who have been successful in securing an award from MedCity’s new ‘Collaborate to Innovate’ scheme. The £2m ‘Collaborate to Innovate programme, led by King’s College London and part-funded by ERDF and HEFCE, is connecting 16 life sciences SMEs with leading academics to address a specific challenge related to their product or service.

New protein discovered in ageing and cancer
9 March 2017

A protein has been found to have a previously unknown role in the ageing of cells, according to an early study by Queen Mary University of London (QMUL). The researchers hope that the findings could one day lead to new treatments for ageing and early cancer.

Blizard students publish in Journal of Physiology
24 February 2017

(pictured first author, Meneka Kanagaratnam)

Time is 'running out' to protect London children: major air pollution warning from top doctors
16 February 2017

More than 280 doctors, nurses and other health professionals have signed a letter to Theresa May calling for national action to dramatically cut the number of diesel cars, vans, taxis and light trucks to protect a generation of young children.

£2.4 million awarded for international trial on major traumatic bleeding
10 February 2017

Queen Mary University of London (QMUL) and NHS Blood & Transplant have been awarded £2.4m from the National Institute for Health Research and Barts Charity to carry out a large multi-centre clinical trial to evaluate a new treatment in major traumatic haemorrhage

David Kelsell, winner of the CHANEL-CERIES Research Award 2016
30 January 2017

Congratulations to Prof David Kelsell, winner of the CHANEL-CERIES Research Award 2016 for his work on skin molecular mechanisms and to the Kelsell Research Group for their recent publication in Nature Communications.

QMUL and BH announce major new initiative in the Life Sciences
25 January 2017

Queen Mary University of London (QMUL) and Barts Health NHS Trust (BH) announce plans for a major new centre for Life Sciences in Whitechapel, home to the Royal London Hospital and a campus of QMUL’s Barts and The London School of Medicine and Dentistry.  

Scar Academy 2016
19 January 2017

Queen Mary University of London in collaboration with Oscare, Belgium organised a two day multidisciplinary conference called: ‘Scar Academy 2016’ last month in London

£1m awarded for global health research
19 January 2017

Researchers from Queen Mary University of London (QMUL) have been awarded grants totalling £1m for medical research projects in low and middle income countries (LMICs)

Barts Innovations in Healthcare Awards - Winners
19 January 2017

Congratulations to the winners of the Barts Innovations in Healthcare Awards November 2016!

Dr Neil McCarthy of the Blizard Institute wins best presentation in ECR session at UCL III Symposium
25 November 2016

Dr Neil McCarthy, pictured above (right) with supervisor Dr Andy Stagg, from the Centre for Immunobiology, was awarded the prize for best oral presentation in the ECR session at the UCL Infection, Immunology and Inflammation Symposium.

Giant ‘nerve cell’ to be built in London’s East End
25 November 2016

Planning permission has been granted for the construction of a new science education space in Whitechapel, East London at Centre of the Cell, Queen Mary University of London (QMUL).

Prof Karim Brohi wins Lifetime Achievement Award for Trauma Research
25 November 2016

Karim Brohi, Professor of Trauma Sciences in the Centre for Neuroscience and Trauma, has received a Lifetime Achievement Award in Resuscitation Science from the American Heart Association.

MS drug may reverse some physical disability
13 October 2016

Alemtuzumab is used in relapsing-remitting MS, the most common form of the disease, in which symptoms alternate between sudden worsening and remission. Because it can cause serious side effects, the drug is generally used in people who have not responded well to other drugs. In this study, however, it was used relatively early in the course of MS.

Multi-drug-resistant TB cure rates higher than expected
15 September 2016

Cure rates for multi-drug-resistant tuberculosis (MDR-TB) in Europe have been estimated to be twice as high as previously thought, according to a research team in the Centre for Immunobiology here at the Blizard Institute, Queen Mary University of London (QMUL).

Most twins should be delivered at 37 weeks to minimise deaths
7 September 2016

Scientists from the Centre for Primary Care and Public Health have analysed the twin pregnancies of more than 30,000 women to identify the ideal delivery period in an attempt to reduce rates of stillbirth.

Vitamin D protects against severe asthma attacks
6 September 2016

Taking oral vitamin D supplements in addition to standard asthma medication could halve the risk of asthma attacks requiring hospital attendance, according to research led by Queen Mary University of London (QMUL).

Blizard AfterTrauma Nominated for Times Higher Education Award 2016
2 September 2016

AfterTrauma –  Nominated for Outstanding Contribution to Innovation and Technology in Times Higher Education Awards 2016

Published in Science: Missing link in genetics could explain conundrum of disease inheritance
8 July 2016

The process by which a mother’s diet during pregnancy can permanently affect her offspring’s attributes, such as weight, could be strongly influenced by genetic variation in an unexpected part of the genome, according to research led by Prof Vardhman Rakyan from the Centre for Genomics and Child Health.

Community-based programme improves depression in chronic pain patients
21 June 2016

Community-based programme improves depression in chronic pain patients

QMUL Barts and The London Medical School ranked second in the UK for medicine in Guardian University League Table 2017
25 May 2016

Queen Mary University of London has been ranked the 34th best university in the UK by The Guardian University Guide 2017.

Blizard Institute Announces its first Paper of the Year Winners
26 February 2016

In February 2015 an initiative was started in the Blizard Institute to recognise outstanding publications by our researchers. Each month, a shortlist is prepared by Prof David Kelsell, Deputy Director for Research, and Prof Graham Hitman, Institute Director, and sent out for all Blizard Institute staff and students to vote on. The winning publication becomes the Blizard Paper of the Month and at the end of the calendar year these are in turn entered into an open vote for Blizard Paper of the Year.

Blizard Researcher Prof Graham Foster makes major breakthrough in treatment of Chronic Hepatitis C
5 January 2016

Congratulations are due to Professor Graham Foster and his team in the Centre for Immunobiology for the below publication. Hepatitis C is a global problem and this treatment will go a long way to reducing the global burden of this disease. The impact of this work cannot be underestimated.  

Blizard Building Marks 10 Year Anniversary
9 December 2015

The iconic RIBA award winning building was opened by Princess Anne in October 2005, and over the past ten years has seen major advances in the research areas of cell biology, genomics, immunology, neuroscience, trauma, primary care and public health.

Students triumph at Biotechnology Entrepreneurs Scheme
29 October 2015

A team of Queen Mary postgraduate students are through to the final of the annual Biotechnology YES (Young Entrepreneur Scheme) competition.

Blizard researchers awarded £3.5m grant to improve prevention of tuberculosis (TB) in South African schoolchildren
12 October 2015

The Medical Research Council (MRC) has awarded a grant of £3.5m to researchers from the Blizard Institute, Queen Mary University of London (QMUL), and University of Cape Town (UCT) to carry out a trial to determine whether a weekly vitamin D supplement can prevent tuberculosis (TB) in South African primary school children.

New study removes cancer doubt for Multiple sclerosis drug
12 October 2015

Researchers from the Blizard Institute at Queen Mary University of London (QMUL) are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis (MS) after new evidence shows it does not increase the risk of cancer as previously thought.

QMUL ranked in top 100 universities in the world
1 October 2015

Queen Mary University of London has been ranked in the top 100 universities in the world in the 2015/16 Times Higher Education World University Rankings:

Two Blizard Institute Researchers Awarded Young Investigator Awards by the International Society for Chemotherapy and Cancer
4 August 2015

Two Blizard Institute Researchers Awarded Young Investigator Awards by the International Society for Chemotherapy and Cancer

Andy Prendergast awarded five-year Wellcome Trust Senior Clinical Fellowship
29 July 2015

Andy Prendergast from the Centre for Genomics and Child Health has been awarded a five-year Wellcome Trust Senior Clinical Fellowship to continue work he is undertaking in Zimbabwe on malnutrition.  His group is exploring interventions to prevent stunting in childhood - an often overlooked form of chronic malnutrition which increases mortality from infections and impairs long-term child development.  His current work on the SHINE trial is evalauting the independent and combined effects of improving water/hygiene/sanitation or infant feeding on stunting.  In his Senior Fellowship, Andy has been awarded £2M from the Wellcome Trust to undertake a trial to evaluate the impact of the antibiotic cotrimoxazole on birth outcomes and growth in rural Zimbabwe.  Antenatal women will be randomized to cotrimoxazole or placebo to see whether antibiotics reduces prematurity and increase birth weight, then infants will be randomized to cotrimoxazole or placebo to evaluate the impact of antibiotics on linear growth by 6 months.  Specimens will be collected from mothers and infants to explore the impact of antibiotics on inflammation, immune function, intestinal inflammation and the microbiota, in laboratory work to be undertaken in Zimbabwe and at the Blizard Institute.

Prof Sandra Eldridge awarded Honorary Fellowship of Royal College of General Practictioners
30 June 2015

Professor Sandra Eldridge from the Centre for Primary Care and Public Health has been awarded an Honorary Fellowship of the Royal College of General Practitioners.

Blizard Institute Researcher Wins Three Minute Thesis Competition
15 June 2015

Dr Protima Amon, Clinical Research Fellow in Paediatric Gastroenterology, won 1st prize in the QMUL Three Minute Thesis (3MT™) competition on Thursday 11th June for her talk entitled: “It’s a bug’s life”. Her PhD work examines the bacteria in children who have inflammation in the intestine.

Blizard researcher develops simple blood test to identify patients at risk of major complications following surgery
8 June 2015

A simple blood test can predict with 90 to 100 per cent accuracy whether a patient is likely to suffer life-threatening complications after major surgery, according to new research from Blizard Institute, Queen Mary University of London, and published in the journal Annals of Surgery.

Professor Silvia Marino elected Vice President of the British Neuro-Oncology Society
1 June 2015

The governing body of the British Neuro-Oncology Society has unanimously supported the nomination of Professor Silvia Marino, based within the Centre for Genomics and Child Health here at the Blizard Institute, as the new Vice President of the society. Professor Marino will serve for two years as Vice President from July 2015 before succeeding the incoming President, Mr David Jellinek, in July 2017. The Society’s mission is to promote research and education in Neuro-Oncology and to improve treatment of patients with tumours of the central nervous system.

Blizard Institute's Prof David Kelsell awarded £1.1 million Cancer Research UK programme grant
9 January 2015

Blizard Institute's Professor David Kelsell and colleagues including Professor Andy Silver have been awarded a £1.1million Cancer Research UK (CRUK) programme grant to work on squamous oesophageal cancer.

Professor of Surgery at the Blizard Institute knighted in New Year’s Honours
9 January 2015

Norman Williams, Professor of Surgery in the Blizard Institute, has been awarded a knighthood in the 2015 New Year’s Honours for services to surgery.

Blizard Institute, as part of QMUL, ranked in the UK’s top 10 for research quality
6 January 2015

The results of the Research Excellence Framework (REF), published 18th December 2014, confirm Queen Mary University of London (QMUL)’s place in the very top group of research-led universities.

Blizard Institute Researcher Dr Neha Pathak wins Cosmopolitan Magazine’s Ultimate Women Award
4 December 2014

Dr Neha Pathak, an Academic Clinical Fellow from Queen Mary University of London, was last night awarded the ‘Ultimate Game Changer’ prize at the Cosmopolitan Ultimate Women Awards.

Centre for Trauma Sciences researcher wins prestigious UK neurosurgery prize
1 December 2014

The 4th Annual Society of British Neurological Surgeons (SBNS) and Neurology & NeuroSurgery Interest Group (NANSIG) conference took place (22/11/14) at the Royal College of Surgeons (RCS), London.  The SBNS comprises some of the most highly respected neurosurgeons and researchers in neuroscience across the UK.  In partnership with NANSIG, it hosts the annual B.Braun Undergraduate Research prize, an annual prize for the most outstanding undergraduate research in neuroscience in the U.K.  This year the prestigious prize was won by Amy Bowes, a final year medical student at the School of Medicine and Dentistry and research assistant for the Centre for Trauma Science’s (C4TS) Neurotrauma and Neurodegeneration Group.

Blizard Institute's Professor Allyson Pollock answers questions about Ebola and the humanitarian crisis of extraordinary proportions facing West Africa
5 November 2014

Professor Allyson Pollock replies to questions on the ebola crisis – originally asked prior to the BBC Politics show on 19 October

Three Blizard Institute researchers win prizes at William Harvey Day 2014
28 October 2014

William Harvey Day – Tuesday 21st October 2014

Brain Tumour Research Centre of Excellence Launches at the Blizard Institute
23 October 2014

A ground-breaking new research partnership with UCL Institute of Neurology (under UCLPartners) and the charity Brain Tumour Research begins today, as the Brain Tumour Research Centre of Excellence launches. The partnership starts a new chapter in long-term, sustainable and continuous research into brain tumours, the biggest cancer killer of children and adults under 40.

New Students! Click here for Induction and Enrolment Details
17 September 2014

QMUL Induction for International Students:

Campaign for real evidence-based medicine launches
7 July 2014

A campaign to put patient care at the centre of evidence-based medicine (EBM) is launched by Professor Trish Greenhalgh, Public Health expert at Centre for Primary Care and Public Health, Blizard Institute, Queen Mary University of London, at the BioMed Central’s Health Services Research conference at Kings’ College London.

New study investigating impact of asthma on school children launches at the Blizard Institute
27 June 2014

Asthma affects one in 11 children and young people in the UK. On average, this is two children in every classroom.  Scientists from the Blizard Institute are launching a new study to measure the impact asthma has on school children, with the aim of improving school life for those with asthma.

Queen Mary announces new research partnership with Brain Tumour Research
10 March 2014

Queen Mary University of London is delighted to announce a ground-breaking new research partnership with UCL Institute of Neurology (under UCLPartners) and the charity Brain Tumour Research. The partnership begins a new chapter in long-term, sustainable and continuous research into brain tumours, the biggest cancer killer of children and adults under 40.   Formally presented to MPs at a reception in Speaker’s House today, the research is led by Professor Silvia Marino, a leading brain tumour scientist and neuropathologist based within Queen Mary’s Blizard Institute. Professor Sheer, also from Queen Mary, and Professor Brandner and Dr Rees at UCL Institute of Neurology will be the other key partners in this initiative.   The research will focus on glioblastoma multiforme (GBM), the most common and most aggressive type of malignant brain tumour found in humans. The aim of the research is to increase our understanding of the cells within the brain from which GBM originates. The team will look at how this particular type of brain tumour develops from normal cells, and determine which genes and biological functions control its behaviour. By uncovering this essential knowledge, the clinical evaluation of each individual patient can be improved and better and more specific drugs which target the tumour cells can be identified.   Silvia Marino, Professor of Neuropathology at Queen Mary University of London, comments: “We know a cure for glioblastoma can and will be found – and this funding boost will hopefully enable significant steps towards a breakthrough. The plan for our centre of excellence is to specialise in adult glioblastoma as we have a wealth of experience in the field, ranging from preclinical experimental models to advanced genomics for direct patient benefit. We also look forward to strengthening collaborative links between us and the UCL Institute of Neurology.” The partnership is part of the charity’s aim for a £20 million investment in brain tumour research over the next five years. Brain Tumour Research aims to establish seven Research Centres of Excellence across the UK, building a ‘critical mass’ of research teams and aiming to bring the UK to the forefront of brain tumour research.   With secure long-term funding, researchers will be able to pursue the sustainable and continuous research so desperately needed by the scientists and clinicians working in the heavily underfunded field of brain tumour research. Promising scientists will be trained up through the ranks and as specialist brain tumour expertise and knowledge builds, experienced researchers can then move between Centres to encourage cross-pollination of the very best thinking at the cutting-edge of brain tumour research.   Sue Farrington Smith, Chief Executive of Brain Tumour Research, comments: “Today we will be forming a powerful new network of researchers in order to accelerate progress in brain tumour research and make a clinical difference. All partners involved share a vision of a sustainable and secure environment for research into brain tumours in the UK, ultimately creating better futures for all those diagnosed and living with a brain tumour. We are determined to do all we can to change this, and to one day find a cure for this devastating disease.”   Queen Mary would also like to thank Barts Charity, for their supporting role in this partnership.

Return to top